Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies is a research paper published in Leukemia (2025). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01 CA251138, R01 CA242020, and R01 CA283364
NCI NIH HHS
Grant: R01 CA283364
NCI NIH HHS
Grant: P50 CA254838
NCI NIH HHS
Grant: R01 CA251138
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
Grant: P50 CA254838-01
NCI NIH HHS
Grant: R01 CA242020
NHLBI NIH HHS
Grant: R01 HL128239
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01HL128239-02
Genetic and molecular basis for SRSF2 mutations in myelodysplasia
National Institutes of Health
Grant: 5R01CA251138-03
Interrogating the minor spliceosome to understand and treat leukemia
National Institutes of Health
Grant: 5R01CA242020-05
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia
National Institutes of Health
Grant: 5R01CA283364-03
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
National Institutes of Health
Grant: 1P50CA254838-01
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
American Society of Hematology
American Society of Clinical Oncology
Edward P. Evans Foundation
Damon Runyon Cancer Research Foundation
FWCI
5.37
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals